![Gilmore O’Neill](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 859 163 $ al 31/05/2026
Gilmore ONeill ocupa el cargo de director médico y vicepresidente ejecutivo de Sarepta Therapeutics, Inc. El Dr. ONeill también forma parte del Consejo de Biotecnología de Massachusetts y de Unity Biotechnology, Inc. y es miembro de la Academia Americana de Neurología. En su anterior carrera ocupó el cargo de Vicepresidente Senior de Biogen, Inc. Gilmore ONeill se licenció en el University College de Dublín y se graduó en la Universidad de Harvard.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
EDITAS MEDICINE, INC. 0,16 % | 03/06/2026 | 248.313 ( 0,16 % ) | 859 163 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| EDITAS MEDICINE, INC. | Director Ejecutivo | 01/06/2022 |
American Academy of Neurology
 American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services Operates a professional society which represents neurologists and neuroscientists | Corporate Officer/Principal | - |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
| UNITY BIOTECHNOLOGY, INC. | Director/Miembro de la Junta | 27/06/2025 |
| APTINYX | Director/Miembro de la Junta | 14/04/2023 |
| SAREPTA THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 17/11/2021 |
| BIOGEN INC. | Director Técnico/Científico/I+D | 01/06/2018 |
| APTINYX | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 9 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University College Dublin
 University College Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Commercial Services |
American Academy of Neurology
American Academy of Neurology Miscellaneous Commercial ServicesCommercial Services Operates a professional society which represents neurologists and neuroscientists | Commercial Services |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
Aptinyx, Inc.
 Aptinyx, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies to treat disorders of the brain and nervous system | Health Technology |
Unity Biotechnology, Inc.
 Unity Biotechnology, Inc. BiotechnologyHealth Technology Engages in the research and development of therapeutics to extend the human healthspan | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
